Please ensure Javascript is enabled for purposes of website accessibility

When Will We Know If COVID Booster Shots Will Be Required?

By Keith Speights - Updated Jun 24, 2021 at 2:22PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's probably going to take several more months.

Millions of Americans have already received two COVID-19 vaccine shots. However, there's a possibility that a third booster dose will be needed. In this Motley Fool Live video recorded on May 17, 2021, Healthcare and Cannabis Bureau Chief Corinne Cardina and Motley Fool contributor Keith Speights discuss when we'll know if a booster shot will be required or not.

Corinne Cardina: Let's talk about the future of booster shots speaking of making a lot of money in the long run. What should investors know? What's the latest in terms of when are we going to know when we'll need more shots, whether it's a year out. Tell me about that.

Keith Speights: Dr. Fauci predicts that we'll know by the fall if a booster shot is going to be required. I think his projection is probably about right. I think sometime in the fall we will know whether or not we're going to need a booster shot or not.

Now, Pfizer (PFE 3.77%) CEO, Albert Bourla, has stated publicly that he thinks a booster shot will likely be required. There are some experts who are less certain about that. We'll see.

Pfizer and Moderna (MRNA -0.37%) are evaluating third booster doses. They are also evaluating in clinical studies variant-specific vaccines. Pfizer expects to have some data from its clinical studies in July, which is right around the corner. Moderna's already reported some positive results from a phase II study earlier this month, actually, for a booster dose and a variant-specific version of its vaccine so it's looking very promising for Moderna.

I wouldn't be surprised if Americans don't actually have to get the third booster shot. But I do expect we're going to require annual vaccinations with a single dose vaccine that targets variants, probably along the lines of what we see with the flu right now where we have annual vaccinations and the flu strains change from year-to-year and they modify the vaccines that are distributed each year.

Personally, I think that's probably what we're going to see. I'm not as confident that these companies are going to benefit from being able to sell third booster doses later this year or early next year.

Corinne Cardina owns shares of Moderna Inc. Keith Speights owns shares of Pfizer. The Motley Fool recommends Moderna Inc. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Pfizer Inc. Stock Quote
Pfizer Inc.
PFE
$50.11 (3.77%) $1.82
Moderna, Inc. Stock Quote
Moderna, Inc.
MRNA
$171.18 (-0.37%) $0.63

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
400%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/14/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.